| View |
|
DRP-8103-01
|
Paracetamol
|
Febrolex
|
250mg/5mL
|
Suspension
|
Analgesic/Antipyretic
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
16 August 2022
|
03 March 2027
|
| View |
|
DRP-8990-03
|
Sevoflurane
|
Aevosha
|
100% v/v Volatile Liquid for Inhalation
|
|
General Anesthetic
|
Lunan Better Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
16 August 2022
|
23 July 2025
|
| View |
|
DRP-9405
|
Timolol (as maleate)
|
Intramol
|
5 mg/mL
|
Ophthalmic Solution
|
Antiglaucoma (Beta blocking agent)
|
Beximco Pharmaceuticals Ltd.
|
Bangladesh
|
Renewal
|
16 August 2022
|
09 February 2028
|
| View |
|
DRP-9637-03
|
PIPERACILLIN (AS SODIUM) + TAZOBACTAM (AS SODIUM)
|
PIPZO HOSPI
|
4 G/500 MG
|
POWDER FOR IV INFUSION
|
ANTIBACTERIAL (PENICILLIN/BETA-LACTAMASE INHIBITOR)
|
INJECTCARE PARENTERALS PVT. LTD.
|
India
|
CLIDP Conversion
|
16 August 2022
|
23 April 2026
|
| View |
|
DRP-9975-06
|
Cefuroxime (as axetil)
|
Bluecef
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
16 August 2022
|
01 July 2026
|
| View |
|
DRP-10312-01
|
Iron + Folic Acid (Vitamin B9)
|
Felicgen
|
100mg (Equivalent t0 314.30 Iron (III) Hydroxide Polymaltose Complex) /1mg Chewable Tablet (Pineapple Flavor)
|
|
Vitamin/Mineral (Antianemic)
|
Saga Lifesciences Limited
|
India
|
CLIDP Conversion
|
16 August 2022
|
13 September 2026
|
| View |
|
DRP-10410-01
|
Citicoline (as Sodium)
|
Citicollen
|
250 mg/ml (1 g/4 ml)
|
Solution for Injection (I.M/I.V)
|
Psychostimulant and Nootropic
|
Kilitch Drugs (India) Ltd.
|
India
|
CLIDP Conversion
|
16 August 2022
|
23 September 2026
|
| View |
|
DRP-10735-02
|
Olmesartan medoxomil
|
OlmeGet
|
40 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
CLIDP Conversion
|
16 August 2022
|
15 November 2026
|
| View |
|
DRP-11154-12
|
Nicardipine Hydrochloride
|
Blicardene
|
1mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropyridine derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
16 August 2022
|
11 February 2027
|
| View |
|
DRP-11189-01
|
Cisplatin
|
Cispollen
|
10 mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Antineoplastic
|
|
India
|
CLIDP Conversion
|
16 August 2022
|
11 February 2027
|
| View |
|
DRP-11492-01
|
Omeprazole (as sodium)
|
ACIPRAZ
|
40mg
|
Lyophilized Powder for Injection (IV Infusion)
|
Proton Pump Inhibitor (PPI)
|
Jodas Expoim Pvt. Ltd.
|
India
|
CLIDP Conversion
|
16 August 2022
|
17 March 2027
|
| View |
|
DRP-11691-02
|
Montelukast (as sodium) + Levocetirizine hydrochloride
|
Unbranded
|
10 mg/5 mg
|
Film-Coated Tablet
|
Leukotriene Receptor Antagonist/Antihistamine
|
Akums Drugs & Pharmaceuticals Ltd. (Plant I - Solid Oral Dosage Facility)
|
India
|
CLIDP Conversion
|
16 August 2022
|
18 April 2027
|
| View |
|
DRP-11939-01
|
Metformin hydrochloride
|
Philmet-500
|
500 mg
|
Film-Coated Tablet
|
Blood Glucose Lowering Drug (Biguanide)
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
16 August 2022
|
20 May 2027
|
| View |
|
DRP-11976-01
|
Salbutamol (as sulfate)
|
Eurosalbu
|
1mg/mL (2.5mg/2.5mL)
|
Solution for Inhalation
|
Selective beta-2-adrenoreceptor agonist
|
Eurolife Healthcare Pvt. Ltd.
|
India
|
Renewal
|
21 February 2024
|
27 December 2028
|
| View |
|
DRP-12138-01
|
Pantoprazole
|
Care-Prazole
|
40mg (equivalent to 44.18mg Pantoprazole Sodium Monohydrate) Lyophilized powder for injection (IM/IV)
|
|
Proton Pump Inhibitor
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
16 August 2022
|
20 June 2027
|
| View |
|
DRP-12215-01
|
Acetylcysteine
|
Philmucil
|
600 mg Effervescent Tablet
|
|
Mucolytic
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
16 August 2022
|
01 July 2027
|
| View |
|
DRP-10150-01
|
Meropenem (as trihydrate)
|
Amsopen
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Aristopharma Ltd.
|
Bangladesh
|
Renewal
|
25 July 2023
|
05 September 2028
|
| View |
DRP-12468_PI_01.pdf
|
DRP-12468
|
Apixaban
|
Eliquis
|
2.5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct Factor Xa Inhibitor)
|
Pfizer Ireland Pharmaceuticals
|
Ireland
|
Renewal
|
16 April 2023
|
28 June 2028
|
| View |
DRP-12469_PI_01.pdf
|
DRP-12469
|
Apixaban
|
Eliquis
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Direct Factor Xa Inhibitor)
|
Pfizer Ireland Pharmaceuticals
|
Ireland
|
Renewal
|
22 February 2024
|
26 February 2029
|
| View |
|
DR-XY46168
|
LEVOFLOXACIN (AS HEMIHYDRATE)
|
VOLECA
|
5MG/ML (500MG/100Ml)
|
SOLUTION FOR INTRAVENOUS INFUSION
|
ANTIBACTERIAL (QUINOLONE)
|
PT Ferron Par Pharmaceuticals
|
Indonesia
|
Renewal
|
16 August 2022
|
24 November 2027
|